Literature DB >> 28027202

Patient Satisfaction and Quality of Life Following Surgery for Hidradenitis Suppurativa.

John J Kohorst1, Christian L Baum, Clark C Otley, Randall K Roenigk, John H Pemberton, Eric J Dozois, Nho V Tran, Mark D P Davis.   

Abstract

BACKGROUND: Hidradenitis suppurativa (HS) is a progressive, recurrent inflammatory disorder.
OBJECTIVE: To assess long-term satisfaction and postoperative perceptions among patients who underwent surgical management of HS.
MATERIALS AND METHODS: A questionnaire was mailed to 499 HS surgical patients to assess surgical outcome, satisfaction, and quality of life.
RESULTS: Of the 499 questionnaires mailed, 113 were returned (22.6% response rate) and 2 were excluded for redundancy. Of the 111 respondents, 65 (58.6%) were female, 91 (82.0%) had Hurley Stage III disease, 88 (79.3%) were treated with excision and 23 (20.7%) with unroofing, 45 (40.5%) had perianal or perineal disease, and 41 (36.9%) had axillary disease. Most patients were satisfied or very satisfied with their surgical results (84.7%; 94 of 111), were glad they underwent surgery (96.3%; 105 of 109), and would recommend surgery to a friend or relative (82.6%; 90 of 109). Most patients were satisfied or very satisfied with the appearance of their healed wound (62.4%; 68 of 109). Retrospective mean quality of life increased significantly from 5 preoperatively to 8.4 postoperatively (p < .001).
CONCLUSION: Hidradenitis suppurativa surgical management was well regarded by patients and should be considered by future patients to limit the morbidity of HS.

Entities:  

Mesh:

Year:  2017        PMID: 28027202     DOI: 10.1097/DSS.0000000000000942

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN: 1076-0512            Impact factor:   3.398


  6 in total

Review 1.  [Surgical treatment options for hidradenitis suppurativa/acne inversa].

Authors:  L Scholl; S Hessam; S Reitenbach; F G Bechara
Journal:  Hautarzt       Date:  2018-02       Impact factor: 0.751

2.  Factors influencing the local cure rate of hidradenitis suppurativa following wide local excision.

Authors:  Ledibabari M Ngaage; Yinglun Wu; Shealinna Ge; Selim Gebran; Fan Liang; Erin M Rada; Arthur J Nam; Ronald P Silverman; Yvonne M Rasko
Journal:  Int Wound J       Date:  2019-11-03       Impact factor: 3.315

Review 3.  Surgical Management of Hidradenitis Suppurativa: A Narrative Review.

Authors:  Surbhi Chawla; Connor Toale; Marie Morris; A M Tobin; Dara Kavanagh
Journal:  J Clin Aesthet Dermatol       Date:  2022-01

Review 4.  North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part I: Diagnosis, evaluation, and the use of complementary and procedural management.

Authors:  Ali Alikhan; Christopher Sayed; Afsaneh Alavi; Raed Alhusayen; Alain Brassard; Craig Burkhart; Karen Crowell; Daniel B Eisen; Alice B Gottlieb; Iltefat Hamzavi; Paul G Hazen; Tara Jaleel; Alexa B Kimball; Joslyn Kirby; Michelle A Lowes; Robert Micheletti; Angela Miller; Haley B Naik; Dennis Orgill; Yves Poulin
Journal:  J Am Acad Dermatol       Date:  2019-03-11       Impact factor: 15.487

Review 5.  Office-Based Surgical Intervention for Hidradenitis Suppurativa (HS): A Focused Review for Dermatologists.

Authors:  Drew K Saylor; Nicholas D Brownstone; Haley B Naik
Journal:  Dermatol Ther (Heidelb)       Date:  2020-05-20

Review 6.  TNF-α inhibitors in the treatment of hidradenitis suppurativa.

Authors:  Kevin T Savage; Kelsey S Flood; Martina L Porter; Alexa B Kimball
Journal:  Ther Adv Chronic Dis       Date:  2019-05-27       Impact factor: 5.091

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.